BAYER AG NA O.N.
Commented by Stefan Feulner on December 8th, 2020 | 10:02 CET
Nio, Desert Gold, Bayer - Don't miss these opportunities!
If in March 2020 before the first lockdown due to the Corona pandemic began you had consistently filled your portfolio with shares, primarily with papers from the technology sector, you would be happy to see growth rates of several 100%. However, one does not earn money on the stock market with ifs and buts. The good news is that there are always new opportunities that you can take advantage of without any ifs and buts.
Read
Commented by André Will-Laudien on December 3rd, 2020 | 11:51 CET
Bayer, Carnival, Silver Viper - Rough weather on the high seas!
Gold up 60 Dollars! Precious metals are beginning to recover from their recent decline in the options market. It is often rumored that the sales in gold & silver have to do with raising money from the prominent market players. Short Gold - Long Nasdaq. The NDX, in any case, climbed to a new all-time high yesterday. In the face of renewed speculation frenzy, which also drove the Bitcoin price back to record highs, some financial media have revived the old argument. The Blockchain creature would be the new gold is the slogan, but some Tweets also show, e.g., from market analyst Fred Hickey, why Bitcoin should not be confused with the yellow metal: "The history of gold is 3,000 years old - that of Bitcoin not even 10 - and gold has a natural attraction!" Currently, the value ratio is 10:1 - Gold analysts see the price at over USD 20,000 in 2025, but Bitcoin already costs that today.
Read
Commented by Stefan Feulner on December 2nd, 2020 | 11:18 CET
Everfuel, Fokus Mining, Bayer - you need to know that!
When greed is at its greatest and development at its peak, the milkmaids buy and it's in the BILD newspaper. At the moment, the hydrogen trend has not yet reached that point. Nevertheless, it is all the more essential to take a closer look at the facts and figures. Many things that are still celebrated today can quickly turn into the negative and speaking of turning, the gold chart has held at a critical support level. Here, after the sell-off, there are good opportunities to enter gold mines once again.
Read
Commented by Stefan Feulner on November 11th, 2020 | 13:22 CET
NEL ASA, dynaCERT, Bayer: Reallocation offers excellent opportunities
After yesterday's triumphant announcement regarding a possible vaccine against the Corona Virus, a rift in the stock market seems to be in full swing. Highly praised tech shares and the profiteers of the Corona Crisis are falling through the bank. In contrast, there is a rebirth of the old economy and cyclical stocks. Oil stocks are also picking up again. The hope for an economic revival is becoming more tangible and creates excellent opportunities for the Fallen Angels.
Read
Commented by Stefan Feulner on November 9th, 2020 | 10:50 CET
BioNTech, Defense Metals, Bayer: Earn money countercyclically
It is complete. After a tense struggle and four days of counting votes, Joe Biden is declared the 46th President of the United States of America. So the Twitter tirades of the defeated Donald Trump should be history. The traces Trump left behind during his four-year reign, however, are likely to keep the government busy for some time to come. Some things, such as the withdrawal from the climate agreement, can be quickly repaired. Biden will carefully weigh up what is "in" and what is "out" on different points of the "America First" program imposed by the predecessor.
Read
Commented by Stefan Feulner on October 26th, 2020 | 09:45 CET
NEL ASA, Almonty Industries, Bayer - Nervousness brings the leverage!
The stock market is restless. Too much uncertainty currently dominates the market. "Crazy Donald" or "Sleepy Joe"? What is the future of the pandemic? Will a hard Brexit with the E.U. follow the British threats? These are the short-term questions that are certainly not likely to ensure peaceful trading on the world's stock markets. However, high volatilities also offer great opportunities. In recent weeks, the Bayer AG share has also been subject to significant fluctuations. Is everything now included in the price, or is the decline continuing? It remains exciting.
Read
Commented by Stefan Feulner on October 15th, 2020 | 13:16 CEST
Bayer, Triumph Gold, BioNTech - decisive phase!
Almost everyone knows the philosophies proclaimed by the great and wise stock market gurus. “Never try catch a falling knife" or "buy on the sound of cannons, sell on the sound of trumpets”. What is true? In the case of Bayer, after the Monsanto disaster, possibly higher than planned fines and a cracking profit warning, one might think that everything has already been priced in. However, it is still not known how and when the Monsanto disaster will end. The fact is, there are other, more appealing papers at the moment ...
Read
Commented by André Will-Laudien on October 13th, 2020 | 13:34 CEST
Bayer, Barrick, Desert Gold: In Gold we trust!
The global economy moving at different speeds. In the USA, the ISM index for services is once again expanding slightly. In China, the mood in the service industry is once again pointing to a veritable recovery. In the eurozone, the economic sentiment examined by the analyst firm, Sentix, remains robust but without any new highs. Even with the rising infection rate, the pandemic will come to an end eventually. In Germany, economic data such as industrial orders, production, and exports, showed a slight slowdown in August. Nevertheless, the stock markets are swinging to new heights daily, as the latent threat from the infection necessitates further liquidity packages from governments. This monetary policy continues to imply very low-interest rates, a weakening USD, and rising inflation expectations. This environment should keep the demand for precious metals at least at a high level, so we remain on the lookout.
Read
Commented by Mario Hose on September 29th, 2020 | 10:51 CEST
BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results
Investors' expectations of developments can drive the share price. When it comes to solving a problem or creating needs, the interest of the capital market is particularly high. Things get exciting for investors when the business model offers the possibilities of scalability. Attractive investment opportunities can be created in the fields of health and medicine, which offer extraordinary return opportunities.
Read
Commented by Mario Hose on September 22nd, 2020 | 09:20 CEST
Almonty, BASF, Bayer: where is it worth starting now?
The start of the week was marked by price losses. In Europe and North America, the leading indices closed in the red. The fear of further effects of the Corona Pandemic has dampened market sentiment. Given that the banknote presses are still running, the breather on the capital markets is again likely to be short-lived. At the time when a vaccine against Covid-19 receives approval, the economy will once again experience an unleashed boom - provided that people can and may want to return to their jobs. Which shares are worthwhile now?
Read